Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF)
OTCMKTS · Delayed Price · Currency is USD
5.20
+2.19 (72.76%)
At close: Nov 7, 2025

RAJAF Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-0.15-0.230.75-0.72-0.49
Depreciation & Amortization
0.210.510.140.080
Loss (Gain) From Sale of Assets
--0---
Other Operating Activities
0.110.02-0.550.30.37
Change in Accounts Receivable
-0.010-0--0.01
Change in Inventory
-0.36-0.12-0.19--
Change in Accounts Payable
0.080.10.18--
Change in Income Taxes
-0.0300.02--
Change in Other Net Operating Assets
0.110.02-0.03-0.06-0.02
Operating Cash Flow
-0.040.310.36-0.32-0.37
Operating Cash Flow Growth
--13.26%---
Capital Expenditures
--0.35-0.32--0.1
Sale of Property, Plant & Equipment
-0.04---
Other Investing Activities
---0-0-0.01
Investing Cash Flow
--0.31-0.32-0-0.11
Short-Term Debt Issued
--0.010.310.18
Total Debt Issued
--0.010.310.18
Short-Term Debt Repaid
-----0.08
Total Debt Repaid
-----0.08
Net Debt Issued (Repaid)
--0.010.310.1
Issuance of Common Stock
----0.23
Other Financing Activities
---0.05-0.060.25
Financing Cash Flow
---0.030.250.57
Foreign Exchange Rate Adjustments
00.01-0-0.010
Net Cash Flow
-0.030.010.01-0.080.1
Free Cash Flow
-0.04-0.040.04-0.32-0.47
Free Cash Flow Margin
-2.88%-2.97%4.56%-602.91%-
Free Cash Flow Per Share
----0.00-0.01
Levered Free Cash Flow
-0.061.360.541.53-0.08
Unlevered Free Cash Flow
-0.051.370.561.53-0.08
Change in Working Capital
-0.20.01-0.02-0.06-0.03